High frequency of p53 gene mutation in adenocarcinomas of the gallbladder

Cancer Epidemiology Biomarkers and Prevention

Volumn 5, Issue 6, 1996, Pages 461-466

  Fujii, Kiyomu ^a   Yokozaki, Hiroshi ^a   Yasui, Wataru ^a   Kuniyasu, Hiroki ^a   Hirata, Manabu ^a   Kajiyama, Goro ^a   Tahara, Eiichi ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CARCINOGENESIS; DNA SEQUENCE; EXON; FEMALE; GALLBLADDER CARCINOMA; GENE FREQUENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADULT; AGED; BASE COMPOSITION; DNA; DNA MUTATIONAL ANALYSIS; FEMALE; GALLBLADDER; GALLBLADDER NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030003897     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Marshall, C. J. Tumor suppressor genes. Cell, 70: 313-316, 1991.
2. Vogelstein, B., and Kinzler, K. W. p53 function and dysfunction. Cell, 70: 524-526, 1992.
3. Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hosteller, R., Cleary, K., Bigner, S. H., Davidson, N., Baylin, S., Devilee, P., Glover, T., Collins, F. S., Weston, A., Modali, R., Harris, C. C., and Vogelstein, B. Mutations in the p53 gene occur in diverse human tumor types. Nature (Lond.), 342: 705-708, 1989.
4. Hollstein, M. C., Sidransky, D., Vogelstein, B., and Harris, C. C. p53 mutations in human cancers. Science (Washington, DC), 253: 49-50, 1991.
5. Sano, T., Tsujino, T., Yoshida, K., Nakayama, H., Haruma, K., Ito, H., Nakamura, Y., Kajiyama, G., and Tahara, E. Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas. Cancer Res., 51: 2926-2931, 1991.
6. Yokozaki, H., Kuniyasu, H., Kitadai, Y., Nishimura, K., Todo, H., Ayhan, A., Yasui, W., Ito, H., and Tahara, E. p53 point mutations in human gastric carcinomas. J. Cancer Res. Clin. Oncol., 119: 67-70, 1992.
7. Tahara, E. Molecular biology of gastric cancer. World J. Surg., 19: 484-490, 1995.
8. Hollstein, M. C., Metcalf, R. A., Welsh, J. A., Montesano, W. R., and Harris, C. C. Frequent mutation of p53 gene in human esophageal cancer. Proc. Natl. Acad. Sci. USA, 87: 9958-9961, 1990.
9. Baker, S. J., Fearon, E. R., Nigro, J. M., Hamilton, S. R., Preisinger, A. C., Jessup, J. M., van Tuinen, P., Ledbetter, D. H., Baker, D. F., Nakamura, Y., White, R., and Vogelstein, B. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science (Washington, DC), 244: 217-221, 1989.
10. Hollstein, M. C., Peri, L., Mandard, A. M., Welsh, J. A., Montesano, W. R., Metcalf, R. A., and Harris, C. C. Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence ras mutations. Cancer Res., 51: 4102-4106, 1991.
11. Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., and Harris, C. C. Mutational hot spot in the p53 gene in human hepatocellular carcinomas. Nature (Lond.), 350: 427-428, 1991.
12. Harris, C. C. Chemical and physical carcinogens: advances and perspectives for the 1990. Cancer Res., 57 (Suppl.): 5011s-5086s, 1991.
13. Albores-Saavedra, J., and Henson, D. E. Tumors of the gallbladder and extrahepatic bile ducts. In: Atlas of Tumor Pathology, Ser. 2, Fasc. 22. Washington DC: Armed Forces Institute of Pathology, 1986.
14. Teh, M., Wee, A., Path, M. R. C., and Raju, G. C. An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas. Cancer (Phila.), 74: 1542-1545, 1994.
15. Oohashi, Y., Watanabe, H., Ajioka, Y., and Hatakeyama, K. p53 immunostaining distinguishes malignant from benign lesions of the gallbladder. Pathol. Int., 45: 58-65, 1995.
16. Albores-Saavedra, J., Henson, D. E., and Sobin, L. H. Histological typing of tumors of the gallbladder carcinoma and extrahepatic bile ducts. In: WHO International Histological Typing of Tumors. Berlin: Springer-Verlag, 1992.
17. Beahrs, O. H., Henson, D. E., Hutter, R. V. P., and Kennedy, B. J. (eds.). Manual for Staging of Cancer (Ed. 4), pp. 93-95. Philadelphia: J. B. Lippincott Co., 1992.
18. Impraim, C. C., Saiki, R. K., Erlich, H. A., and Teplitz, R. L. Analysis of DNA extracted from formalin-fixed, paraffin-embedded tissue by enzymatic amplification and hybridization with sequence-specific oligonucleotides. Biochem. Biophys. Res. Commun., 143: 710-716, 1987.
19. Ara, S., Lee, P. S., Hansen, M. F., and Saya, H. Codon 72 polymorphism of the TP 53 gene. Nucleic Acids Res., 18: 4961, 1990.
20. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. p21 is a universal inhibitor of cyclin kinases. Nature (Lond.), 360: 701-704, 1993.
21. El-Deiry, W., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, J. M., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.